Heron Therapeutics | HRTX - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
ALKERMES USD 456.48M 48.85M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
ANI Pharmaceuticals USD 274.47M 19.04M 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
Eisai JPY 253.13B 26.12B 2026-06
Emergent BioSolutions USD 290.1M 134.2M 2023-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 215.32M 36.77M 2026-06
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Merck USD 12.21B 435M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Omeros USD 8.08M 440K 2024-06
Pacira USD 132.42M 6.78M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Veracyte USD 54.18M 4.06M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06